Literature DB >> 22798112

The effect of hepatotropic virus (HBV-HCV) infections on tuberculin skin test in patients with cirrhosis.

Mehmet Çelikbilek1, Haldun Selçuk, Uğur Yilmaz.   

Abstract

BACKGROUND/AIMS: To optimize the detection of infected persons and to treat latent tuberculosis infection are essential in patients taking part in a liver transplantation program. The tuberculin skin test is currently used to detect Mycobacterium tuberculosis infection and has widespread usage. This study aimed to evaluate the effect of hepatitis B and C viruses on tuberculin skin test results in patients taking part in the liver transplantation program in our center.
MATERIAL AND METHODS: A total of 90 cirrhosis patients who participated in the liver transplantation program between January 2004 and February 2005 were included in this study. None of the patients displayed signs of active tuberculosis during the follow-up.
RESULTS: The mean indurations of the tuberculin skin test were found to be 14.7±6.9 mm in patients with a viral etiology and 6.1±5.4 mm in those with a non-viral etiology. The tuberculin skin test findings were significantly higher in end-stage liver disease caused by viruses than those with a non-viral etiology (p<0.05). The mean induration of the tuberculin skin test in Child B patients was found to be 7.15±6.4 mm, while in Child C patients it was 12.64±7.5 mm. In Child C patients, the tuberculin skin test scores were significantly higher than in Child B patients (p<0.05).
CONCLUSIONS: These observations show the need for new methods to detect latent Mycobacterium tuberculosis infection in liver transplant candidates. Further research is needed to understand the reasons for the higher tuberculin skin test results with a viral etiology and in Child C patients.

Entities:  

Mesh:

Year:  2012        PMID: 22798112     DOI: 10.4318/tjg.2012.0341

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  2 in total

1.  Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis.

Authors:  Praveen Sharma; Pankaj Tyagi; Vikas Singla; Naresh Bansal; Ashish Kumar; Anil Arora
Journal:  J Clin Exp Hepatol       Date:  2015-01-27

Review 2.  Antitubercular therapy in patients with cirrhosis: challenges and options.

Authors:  Naveen Kumar; Chandan Kumar Kedarisetty; Sachin Kumar; Vikas Khillan; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.